Las Vegas, NV -- (SBWIRE) -- 12/31/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more. EquityObserver.com issues a special report on the following stocks:AVEO Pharmaceuticals, Inc.(NASDAQ:AVEO),Dejour Energy Inc (USA)(NYSEMKT:DEJ),VisionChina Media Inc (ADR)(NASDAQ:VISN),AEterna Zentaris Inc. (USA)(NASDAQ:AEZS)
AVEO Pharmaceuticals, Inc.(NASDAQ:AVEO)managed to keep its gain at 8.02% on above-normal volume of 1.47Mshares. The stock settled at $1.75, after floating in a range of $1.60 - 1.76. Its latest price has reached market capitalization of $90.76M. Its 52-week range has been $1.53 - 8.94. AVEO Pharmaceuticals, Inc. is a cancer therapeutics company discovering, developing and commercializing targeted cancer therapies.
How Should Investors Trade AVEO Now?Don’t Miss out a Special Trend Analysis
Dejour Energy Inc (USA)(NYSEMKT:DEJ)trading on a volume of 1.40M shares, higher than its standard daily volume. Shares have been closed at $0.117. Over the last twelve months, the stock has lost-46.11% and faced a worst price of $0.09.Dejour Energy Inc. is engaged in the business of acquiring, exploring and developing energy projects with a focus on oil and gas exploration in Canada and the United States
Is DEJ a Solid Investment at These Levels?Read This Report for Details
VisionChina Media Inc (ADR)(NASDAQ:VISN)is down at $23.80 on above- normal volume of 1.38Mshares during the last trading day. The stock has its 12-month range $1.77 - 31.63. Its Intraday range is $23.11 - 31.00.VisionChina Media Inc. (VisionChina) operates out-of-home advertising network using real-time mobile digital television broadcasts to deliver content and advertising on mass transportation systems in China based on the number of displays.
How Should Investors Trade VISN Now?Don’t Miss out a Special Trend Analysis
In the last trading day, AEterna Zentaris Inc. (USA)(NASDAQ:AEZS)is on low volume, trading at a volume of versus its average daily volume ratio 1.33M/2.76Mshares. At $1.40, the stock has attained market capitalization of 63.18M.Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company’s pipeline encompasses compounds at all stages of development.
Will Investors Buy AEZS After Reading This News?Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)